These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 15187202

  • 1. Omalizumab: a novel therapy for allergic asthma.
    Davis LA.
    Ann Pharmacother; 2004; 38(7-8):1236-42. PubMed ID: 15187202
    [Abstract] [Full Text] [Related]

  • 2. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L, Sorkness CA.
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monoclonal anti-IgE antibody: a novel therapy for allergic airways disease.
    Berger WE.
    Ann Allergy Asthma Immunol; 2002 Feb; 88(2):152-60; quiz 161-2, 208. PubMed ID: 11868919
    [Abstract] [Full Text] [Related]

  • 6. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N.
    J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
    Holgate S, Bousquet J, Wenzel S, Fox H, Liu J, Castellsague J.
    Curr Med Res Opin; 2001 Aug; 17(4):233-40. PubMed ID: 11922396
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW, Massanari M, Kianifard F, Geba GP.
    Curr Med Res Opin; 2007 Oct; 23(10):2379-86. PubMed ID: 17711616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Omalizumab: efficacy in allergic disease.
    Spector S.
    Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883
    [Abstract] [Full Text] [Related]

  • 16. Reduction of the total IgE level by omalizumab in children and adolescents.
    Steiss JO, Strohner P, Zimmer KP, Lindemann H.
    J Asthma; 2008 Apr; 45(3):233-6. PubMed ID: 18415832
    [Abstract] [Full Text] [Related]

  • 17. Omalizumab, a monoclonal antibody against IgE for the treatment of allergic diseases.
    Solèr M.
    Int J Clin Pract; 2001 Sep; 55(7):480-3. PubMed ID: 11594260
    [Abstract] [Full Text] [Related]

  • 18. Omalizumab: overview of pharmacology and efficacy in asthma.
    Ledford DK.
    Expert Opin Biol Ther; 2009 Jul; 9(7):933-43. PubMed ID: 19527111
    [Abstract] [Full Text] [Related]

  • 19. [Omalizumab (Xolair). Product description].
    Laursen LC.
    Ugeskr Laeger; 2007 Mar 12; 169(11):993-5. PubMed ID: 17371630
    [Abstract] [Full Text] [Related]

  • 20. Omalizumab as add-on therapy to inhaled steroids for asthma.
    Hadj Tahar A.
    Issues Emerg Health Technol; 2004 Jun 12; (58):1-4. PubMed ID: 15455487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.